Annual Document 2009

Annual document for the 2009 financial year in accordance with § 10, paragraph 1 of the German Securities Prospectus Act.

The following overview contains references to the information published in the 2009 financial year in accordance with the provisions referred to in § 10, paragraph 1 of the German Securities Prospectus Act.

In the event that an internet link given here is not accessible or not functioning, we can provide you with the information in printed form free of charge. Please contact our Corporate Communications team.

Financial Reports

Date Document
02/26/2009 Consolidated Financial Statements 2008 of MorphoSys Group (IFRS) (PDF, 1 MB)
03/27/2009 Financial Statements 2008 of MorphoSys AG (HGB) (PDF, 664 KB)
03/27/2009 Annual Report 2008 (PDF, 10.2 MB)
04/28/2009 3-Months-Report 2009 (PDF, 1 MB)
07/29/2009 6-Months-Report 2008 (PDF, 1 MB)
10/28/2009 9-Months-Report 2008 (PDF, 1 MB)

Financial Calendar 2009

Date Event
02/26/2009 YE Press Conference and Analyst Meeting in Frankfurt/Main (Germany) and Publication of Financial Statements 2008
04/28/2009 Publication of 3-Months-Report 2009
05/14/2009 Ordinary Annual Shareholders’ Meeting 2009 in Munich (Germany)
07/29/2009 Publication of 6-Months-Report 2009
10/28/2009 Publication of 9-Months-Report 2009

Preliminary Announcement on the Disclosure of Financial Statements

Date Event
02/25/2009 Announcement acc. to §§ 37v-x WpHG: Announcement according to articles 37v, 37w, 37x ff. WpHG [Securities Trading Act] with the aim of a Europe-wide distribution

Ad Hoc-Releases according to § 15 WpHG

No announcements in 2009.

Publication of Directors’ Dealings pursuant to § 15a WpHG

Date

Name and Function

Transaction Type, Number & Security

Date, Place, Price & Transaction Volume

Nov 06, 09

Dave Lemus, CFO

Purchase of 2,100 MorphoSys shares (after excercise of 2,100 stock options)

Nov. 06, 2009, off-exchange,
EUR 10,45 (strike price of stock options),
EUR 21,945.00

Nov 06, 09

Dave Lemus, CFO

Sale of 2,595 MorphoSys shares
(after exercise of 2,595 stock options)

Nov. 06, 2009, XETRA,
EUR 17,43 (average),
EUR 45,230.85

Nov 06, 09

Dave Lemus, CFO

Sale of 9,105 MorphoSys shares
(after exercise of 9,105 stock options)

Nov. 05, 2009, XETRA,
EUR 17,34 (average),
EUR 157,880.70

Nov 06, 09

Dave Lemus, CFO

Sale of 13,500 MorphoSys shares
(after exercise of 13,500 stock options)

Nov. 04, 2009, XETRA,
EUR 17,41 (average),
EUR 235,035.00

Nov 06, 09

Dave Lemus, CFO

Sale of 10,800 MorphoSys shares
(after exercise of 10,800 stock options)

Nov. 02, 2009, XETRA,
EUR 17,61 (average),
EUR 190,188.00

Oct 07, 09

Dave Lemus, CFO

Purchase of 3,000 MorphoSys shares (after excercise of 3,000 stock options)

Oct. 05, 2009, off-exchange,
EUR 10,45 (strike price of stock options),
EUR 31,350.00

Oct 07, 09

Dave Lemus, CFO

Sale of 15,000 MorphoSys shares
(after exercise of 15,000 stock options)

Oct. 1, 2009, XETRA,
EUR 17,01 (average),
EUR 255,150.00

Oct 07, 09

Dave Lemus, CFO

Sale of 17,595 MorphoSys shares
(after exercise of 17,595 stock options)

Sep. 30, 2009, XETRA,
EUR 17.16 (average),
EUR 301,930.20

Sep 03, 09

Dr. Arndt Schottelius, CDO

Purchase of 500 MorphoSys shares

Sep. 01, 2009, XETRA,
EUR 15.54,
EUR 7,770.00

Aug 21, 09

Dr. Simon Moroney, CEO

Sale of 9,708 MorphoSys shares
(after exercise of 9,708 stock options)

Aug. 21, 2009, XETRA,
EUR 16.18 (average),
EUR 157,075.44

Aug 21, 09

Dr. Simon Moroney, CEO

Sale of 11,754 MorphoSys shares
(after exercise of 11,754 stock options)

Aug. 17, 2009, XETRA,
EUR 16.34 (average),
EUR 192,060.36

Aug 7, 09

Dr. Simon Moroney, CEO

Purchase of 10,002 MorphoSys shares (after excercise of 10,002 stock options)

Jul. 31, 2009, off-exchange, EUR 6.93 (strike price of stock options),
EUR 69,313.86

Aug 7, 09

Dr. Simon Moroney, CEO

Sale of 4,194 MorphoSys shares
(after exercise of 4,194 stock options)

Aug. 6, 2009, XETRA,
EUR 16.30 (average),
EUR 68,362.20

Aug 7, 09

Dr. Simon Moroney, CEO

Sale of 2,457 MorphoSys shares
(after exercise of 2,457 stock options)

Aug. 5, 2009, XETRA,
EUR 16.30 (average),
EUR 40,049.10

Aug 7, 09

Dr. Simon Moroney, CEO

Sale of 12,645 MorphoSys shares
(after exercise of 12,645 stock options)

Aug. 4, 2009, XETRA,
EUR 16.42 (average),
EUR 207,630.90

Aug 7, 09

Dr. Simon Moroney, CEO

Sale of 7,239 MorphoSys shares
(after exercise of 7,239 stock options)

Aug. 3, 2009, XETRA,
EUR 16.32 (average),
EUR 118,140.48

Aug 7, 09

Dr. Simon Moroney, CEO

Sale of 17,001 MorphoSys shares
(after exercise of 17,001 stock options)

Jul. 31, 2009, XETRA,
EUR 16.37 (average),
EUR 278,306.37

Notifications of Participating Interest (§§ 25 und 26 WpHG)

Date Notification
03/06/2009 Massachusetts Mutual Life Insurance Company
03/30/2009 Massachusetts Mutual Life Insurance Company
04/24/2009 Massachusetts Mutual Life Insurance Company
04/24/2009 Massachusetts Mutual Life Insurance Company
04/24/2009 Massachusetts Mutual Life Insurance Company
05/18/2009 Massachusetts Mutual Life Insurance Company
07/10/2009 Massachusetts Mutual Life Insurance Company

Publications According to Exchange Rules

No announcements in 2009.

Development of Number of Voting Rights and Shares

Date Document
01/30/2009 Voting Rights as of 01/30/2009
07/31/2009 Voting Rights as of 07/31/2009
08/31/2009 Voting Rights as of 08/31/2009
09/30/2009 Voting Rights as of 09/30/2009
10/30/2009 Voting Rights as of 10/30/2009
11/30/2009 Voting Rights as of 11/30/2009

Annual Shareholders’ Meeting 2009

Date Document
03/27/2009 Agenda of Annual Shareholders’ Meeting 2009 (PDF, 47 KB)